1.Study on the immunophenotypes of bone marrow cells from patients with myelodysplastic syndromes and its clinical implications.
Jian-Ying WANG ; Xiao-Ming LI ; Fa-Ju LI ; Xin-Gui CHEN
Journal of Experimental Hematology 2002;10(2):173-174
The phenotypes of the bone marrow cells in various subtypes of myelodysplastic syndromes (MDS) and its clinical implication were explored. The antigen expression of a panel of antigens expressed in marrow cells from 30 patients with subtypes of MDS was assayed by alkaline phosphatase anti-alkaline phosphatase method. The results showed that the expression of myeloid antigens appeared abnormality, CD13 and CD33, found on granulocyte and macrophage precursors, increased, and CD15 decreased. There were no significant changes for monocytic antigen CD14 and lymphoid antigens CD7 and CD10. CD34 was increased in RAEB/RAEB-t and was not increased in RA/RAS patients. CD71, expressed by erythroblast and proliferative cells, was higher in all subtypes of MDS than that in control group. It is suggested that the bone marrow cells from MDS patients showed abnormality of more than two series of immunophenotypes, detection of immunophenotype in MDS cells might be contributed to the diagnosis and predicting prognosis.
Adult
;
Aged
;
Antigens, CD
;
analysis
;
Antigens, CD34
;
analysis
;
Antigens, CD7
;
analysis
;
Antigens, Differentiation, B-Lymphocyte
;
analysis
;
Antigens, Differentiation, Myelomonocytic
;
analysis
;
Bone Marrow Cells
;
immunology
;
CD13 Antigens
;
analysis
;
Female
;
Humans
;
Immunophenotyping
;
Lewis X Antigen
;
analysis
;
Lipopolysaccharide Receptors
;
analysis
;
Male
;
Middle Aged
;
Myelodysplastic Syndromes
;
immunology
;
pathology
;
Neprilysin
;
analysis
;
Receptors, Transferrin
;
Sialic Acid Binding Ig-like Lectin 3
2.Flow cytometric immunophenotyping in fine-needle aspiration of lymph nodes.
Jae Gul CHUNG ; Gyung Yub GONG ; Joo Ryung HUH ; Shin Kwang KHANG ; Jae Y RO
Journal of Korean Medical Science 1999;14(4):393-400
Fine-needle aspiration (FNA) of lymph nodes has been regarded as a useful method in the diagnosis of lymphadenopathy. However, this procedure has been shown to be of limited value in the diagnosis of low or intermediate grade malignant lymphomas in some studies. Immunophenotyping is an essential adjunct to cytomorphology for the diagnosis of lymphoma by FNA. Immunophenotyping using flow cytometry (FCM) is rapid, objective and reliable. Using FCM, multiparametric analysis of 33 FNA materials from lymph nodes was performed and profiles of surface markers of lymphoid cells were assessed. In reactive hyperplasia, patterns of cell surface markers were quite variable, but disclosed polyclonality. Most of the B-cell lymphomas showed immunophenotypes for B-cell lineages with their kappa: lambda or lambda: kappa ratio being over 3:1. In T-cell lymphomas, T-cell surface markers were predominantly expressed as well. In conclusion, our results suggest that immunophenotyping of lymph node aspirates is a valuable diagnostic adjunct for lymphoproliferative disorders, particularly in B-cell lymphomas because immunophenotyping can be easily and adequately performed by FCM.
Antigens, CD19/analysis
;
Antigens, CD20/analysis
;
Antigens, CD3/analysis
;
Antigens, CD4/analysis
;
Antigens, CD5/analysis
;
Antigens, CD7/analysis
;
Antigens, CD8/analysis
;
B-Lymphocytes/immunology
;
B-Lymphocytes/chemistry
;
Biopsy, Needle
;
Flow Cytometry/methods*
;
Hodgkin Disease/pathology
;
Human
;
Immunophenotyping
;
Lymph Nodes/pathology
;
Lymph Nodes/chemistry
;
Lymphatic Diseases/pathology*
;
Lymphatic Metastasis/pathology
;
Lymphoma, B-Cell/pathology*
;
Lymphoma, Non-Hodgkin/pathology
;
T-Lymphocytes/immunology
;
T-Lymphocytes/chemistryt
3.Immunologic characteristics and prognosis of acute myeloid leukemia M1.
Journal of Experimental Hematology 2007;15(4):687-691
The study was aimed to investigate the immunological characteristics and prognosis of acute myeloid leukemia (AML) M(1) and to find the main points in immunology to differentiate AML M(1) from M(2), and M(1) from ALL (proB, preB, T). Immunophenotyping was performed in 41 AML M(1) patients by three-color flow cytometry analysis using CD45/SSC gating, meanwhile the cytogenetic analysis was performed in 17 patients. 51 newly diagnosed AML M(2) patients and 58 newly diagnosed ALL patients were used as control at the same time. The results showed that the positive rate of CD33 in M(1) was 100%, which was high in sensitivity, but low in specificity; the positive rate of CD11b, CD15, MPO, CD117 in M(1) were significantly lower than that in M(2) (p < 0.05); the positive rate of T-lineage antigen in Ly + AML M(1) was higher than that in M(2) (p < 0.05); compared with ALL ProB, M(1) had high expression of HLA-DR, simultaneously myeloid antigen CD13, CD15, CD33, CD117, MPO and T-lineage antigen CD4, CD7 were all highly expressed (p < 0.05); compared with ALL PreB, M(1) had high expression of HLA-DR, CD34, meanwhile myeloid antigen CD13, CD15, CD33, CD117, MPO and T-lineage antigen CD4, CD5 were all highly expressed (p < 0.05); as compared with T-ALL, the early-phase antigen HLA-DR, CD34, myeloid antigen CD13, CD15, CD33, CD117, MPO of M(1) were all significantly highly expressed (p < 0.05). In M(1), the complete remission (CR) rate in patients with CD7 positive had no statistical difference from that in patients with CD7 negative (p > 0.05); the CR rate of patients with CD34 positive had no statistical difference from that of patients with CD34 negative (p > 0.05); CR rate in M(1) was lower than that in M(2) (p < 0.05), time to reach CR was longer, the incidence of hyperleukocytic acute leukemia was higher (p < 0.05), CR rate in hyperleukocytic acute leukemia was lower (p < 0.05). It is concluded that the myeloid antigen CD33, CD13 in M(1) are highly expressed, early-phase antigen HLA-DR in M(1) is also highly expressed, but the myeloid antigen CD11b, CD15, MPO, CD117 in M(1) are lowly expressed, T-lineage antigen CD4, CD7 in M(1) are highly expressed in the meantime. There is no definite characteristic marker in immunology to differentiate M(1) from M(2), but as the positive rate of CD11b, CD15, MPO, CD117 in M(1) are significantly lower than that of M(2), CD11b, CD15, MPO, CD117 can be used as reference indicators to differentiate M(1) from M(2). AML M(1), ALL ProB, ALL PreB and T-ALL, which are difficult to differentiate in morphology can be well seperated through the analysis of immunological phenotype. CD117 is mainly expressed in AML, which is useful for the differentiation diagnosis between AML and ALL. The prognosis of M(1) is worse than that of M(2).
Adolescent
;
Adult
;
Antigens, CD
;
analysis
;
Antigens, CD7
;
analysis
;
Antigens, Differentiation, Myelomonocytic
;
analysis
;
CD13 Antigens
;
analysis
;
CD4 Antigens
;
analysis
;
Diagnosis, Differential
;
Female
;
HLA-DR Antigens
;
analysis
;
Humans
;
Immunophenotyping
;
Leukemia, Myeloid, Acute
;
classification
;
diagnosis
;
immunology
;
Male
;
Middle Aged
;
Prognosis
;
Sialic Acid Binding Ig-like Lectin 3
;
Young Adult
4.Frequent CD7 Antigen Loss in Aggressive Natural Killer-Cell Leukemia: A Useful Diagnostic Marker.
Eun Hyung YOO ; Hee Jin KIM ; Seung Tae LEE ; Won Seog KIM ; Sun Hee KIM
The Korean Journal of Laboratory Medicine 2009;29(6):491-496
BACKGROUND: Aggressive natural killer-cell leukemia (ANKL) is a rare neoplasm characterized by systemic proliferation of NK cells. However, the differential diagnosis of NK lymphoproliferative disorders is difficult because of the absence of a distinct diagnostic hallmark. Therefore, to identify diagnostic markers for ANKL, we analyzed the clinical data and laboratory findings obtained for 20 patients with ANKL. METHODS: From January 2000 to July 2007, 20 patients were diagnosed with ANKL on the basis of bone marrow studies. We retrospectively analyzed the clinical features and laboratory findings, including the complete blood count, Epstein-Barr virus status, immunophenotype, and the cytogenetic results. RESULTS: The subjects included 6 women and 14 men (median age, 44 yr; range, 2-70 yr). Cytogenetic studies were performed in 18 patients, and karyotypic abnormalities were observed in 9 patients (50%). None of the cytogenetic abnormalities were constantly observed in all the patients. However, 6q abnormalities were observed in 4 patients (4/18, 22%). The immunophenotype of the leukemic NK-cells was cytoplasmic CD3+, surface CD3-, CD16/56+, CD2+, and CD5-. Notably, the CD7 antigen was absent in 10 patients (50%). When the CD7 loss was combined with cytogenetic abnormalities, clonal markers could be identified in 75% of the ANKL cases. CONCLUSIONS: The CD7 antigen loss was frequently observed in our series of ANKL patients. In conjunction with the cytogenetic findings, this characteristic immunophenotypic finding can serve as a reliable marker for the timely diagnosis of ANKL. Therefore, immunophenotypic analysis of CD7 expression should be included in the diagnosis of NK cell neoplasms.
Adolescent
;
Adult
;
Aged
;
Antigens, CD7/*analysis
;
Blood Cell Count
;
Child
;
Child, Preschool
;
Cytogenetics
;
Female
;
Herpesvirus 4, Human/isolation & purification
;
Humans
;
Immunophenotyping
;
Karyotyping
;
Leukemia, Large Granular Lymphocytic/*diagnosis
;
Male
;
Middle Aged
;
Retrospective Studies
;
Tumor Markers, Biological/*analysis